Fluidigm Corp. (NASDAQ:FLDM) shares traded up 4.4% during trading on Thursday . The stock traded as high as $10.94 and last traded at $10.91, with a volume of 56,435 shares traded. The stock had previously closed at $10.45.

Several research analysts have recently commented on the company. Cantor Fitzgerald reduced their price target on Fluidigm Corp. from $13.00 to $11.00 and set a “buy” rating for the company in a research report on Friday. Mizuho boosted their target price on Fluidigm Corp. from $11.00 to $12.00 and gave the stock a “buy” rating in a research note on Friday. Zacks Investment Research downgraded Fluidigm Corp. from a “buy” rating to a “hold” rating in a research note on Monday, July 11th. Deutsche Bank AG started coverage on Fluidigm Corp. in a research note on Wednesday, June 1st. They set a “buy” rating on the stock. Finally, Leerink Swann dropped their target price on Fluidigm Corp. from $20.00 to $15.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 12th. Five research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $13.94.

The company’s market cap is $264.99 million. The company has a 50 day moving average price of $9.73 and a 200 day moving average price of $8.55.

Fluidigm Corp. (NASDAQ:FLDM) last released its quarterly earnings results on Thursday, August 4th. The company reported ($0.64) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.58) by $0.06. During the same quarter in the prior year, the company posted ($0.53) earnings per share. The company earned $28.20 million during the quarter, compared to analysts’ expectations of $29.62 million. The firm’s revenue was down 1.5% on a year-over-year basis. Analysts expect that Fluidigm Corp. will post ($2.24) EPS for the current fiscal year.

A hedge fund recently bought a new stake in Fluidigm Corp. stock. Marshall Wace LLP acquired a new position in shares of Fluidigm Corp. (NASDAQ:FLDM) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 96,680 shares of the company’s stock, valued at approximately $1,045,000. Marshall Wace LLP owned about 0.34% of Fluidigm Corp. as of its most recent SEC filing.

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.